Characterization of non-lethal West Nile Virus (WNV) infection in horses: Subclinical pathology and innate immune response

Microbial Pathogenesis

Volumn 103, Issue , 2017, Pages 71-79

  Bielefeldt Ohmann, Helle ^a   Bosco Lauth, Angela ^b   Hartwig, Airn Elizabeth ^b   Uddin, M Jasim ^a   Barcelon, Jean ^a   Suen, Willy W ^a   Wang, Wenqi ^a   Hall, Roy A ^a   Bowen, Richard A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Arbovirus; Equine; Flavivirus; Innate immune response; Interferons

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 7; INTERFERON STIMULATED GENE 15; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 22; MYELOID DIFFERENTIATION FACTOR 88; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRUS RNA; AUTACOID; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BRAIN; CONTROLLED STUDY; FLAVIVIRUS INFECTION; GENE EXPRESSION; HISTOPATHOLOGY; HORSE; IMMUNOPHENOTYPING; INNATE IMMUNITY; LEUKOCYTE; LYMPHOID TISSUE; NONHUMAN; ORYCTOLAGUS CUNICULUS; PRIORITY JOURNAL; RABBIT MODEL; UPREGULATION; VIRUS CHARACTERIZATION; VIRUS ENCEPHALITIS; VIRUS ISOLATION; VIRUS STRAIN; WEST NILE VIRUS INFECTION; ANIMAL; HORSE DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; RABBIT; VETERINARY; VIROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALS; BRAIN; CYTOKINES; HORSE DISEASES; HORSES; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LEUKOCYTES; RABBITS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85007134531     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.12.018     Document Type: Article

References (46)

1. [1] Angenvoort, J., Brault, A.C., Bowen, R.A., Groschup, M.H., West Nile viral infection of equids. Vet. Microbiol. 167 (2013), 168–180.
2. [2] Suen, W.W., Prow, N.A., Setoh, Y.X., Hall, R.A., Bielefeldt-Ohmann, H., End-point disease investigation for virus strains of intermediate virulence as illustrated by flavivirus infections. J. Gen. Virol. 97 (2016), 366–377.
3. [3] Venter, M., Human, S., Zaayman, D., Gerdes, G.H., Williams, J., Steyl, J., Leman, P.A., Paweska, J.T., Setzkorn, H., Rous, G., Murray, S., Parker, R., Donnellan, C., Swanepoel, R., Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg. Infect. Dis. 15 (2009), 877–884.
4. [4] Ward, M.P., Schuermann, J.A., Highfield, L.D., Murray, K.O., Characteristics of an outbreak of West Nile virus encephamyelitis in a previously uninfected population of horses. Vet. Microbiol. 118 (2006), 255–259.
5. [5] Bunning, M.L., Bowen, R.A., Cropp, C.B., Sullivan, K.G., Davis, B.S., Komar, N., Godsey, M.S., Baker, D., Hettler, D.L., Holmes, D.A., Biggerstaff, B.J., Mitchell, C.J., Experimental infection of horses with West Nile virus. Emerg. Infect. Dis. 8 (2002), 380–386.
6. [6] Guthrie, A.J., Howell, P.G., Gardner, I.A., Swanepoel, R.E., Nurton, J.P., Harper, C.K., Pardini, A., Groenewald, D., Visage, C.W., Hedges, J.F., Balasuriya, U.B., Cornel, A.J., MacLachlan, N.J., West Nile virus infection of thoroughbred horses in South Africa (2000-2001). Equine. Vet. J. 35 (2003), 601–605.
7. [7] Nielsen, C.F., Reisen, W.K., Armijos, M.V., Maclachlan, N.J., Scott, T.W., High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection. Am. J. Trop. Med. Hyg. 78 (2008), 45–52.
8. [8] Prow, N.A., Tan, C.S., Wang, W., Hobson-Peters, J., Kidd, L., Barton, A., Wright, J., Hall, R.A., Bielefeldt-Ohmann, H., Natural exposure of horses to mosquito-borne flaviviruses in south-east Queensland, Australia. Int. J. Environ. Res. Public. Health 10 (2013), 4432–4443.
9. [9] Prow, N.A., The changing epidemiology of Kunjin virus in Australia. Int. J. Environ. Res. Public. Health 10 (2013), 6255–6272.
10. [10] Conte, A., Candeloro, L., Ippoliti, C., Monaco, F., De Massis, F., Bruno, R., Di Sabatino, D., Danzetta, M.L., Benjelloun, A., Belkadi, B., El Harrak, M., Declich, S., Rizzo, C., Hammami, S., Ben Hassine, T., Calistri, P., Savini, G., Spatio-temporal identification of areas suitable for West Nile disease in the Mediterranean basin and central Europe. PLoS One, 10, 2015, e0146024.
11. [11] Hall, R.A., Broom, A.K., Smith, D.W., Mackenzie, J.S., The ecology and epidemiology of Kunjin virus. Curr. Top. Microbiol. Immunol. 267 (2002), 253–269.
12. [12] Frost, M.J., Zhang, J., Edmonds, J.H., Prow, N.A., Gu, X., Davis, R., Hornitzky, C., Arzey, K.E., Finlaison, D., Hick, P., Read, A., Hobson-Peters, J., May, F.J., Doggett, S.L., Haniotis, J., Russell, R.C., Hall, R.A., Khromykh, A.A., Kirkland, P.D., Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 18 (2012), 792–800.
13. [13] Prow, N.A., Edmonds, J.H., Williams, D.T., Setoh, Y.X., Bielefeldt-Ohmann, H., Suen, W.W., Hobson-Peters, J., van den Hurk, A., Pyke, A., Hall-Mendelin, S., Northill, J., Johansen, C.A., Warrilow, D., Wang, J., Kirkland, P.D., Doggett, S., Andrade, C.C., Brault, A.C., Khromykh, A.A., Hall, R.A., Genetic and phenotypic markers of virulence and evolution in West Nile virus strains circulating in Australia over the last 50 years. Emerg. Infect. Dis. 22 (2016), 1353–1362.
14. [14] Prow, N.A., Hewlett, E.K., Faddy, H.M., Coiacetto, F., Wang, W., Cox, T., Hall, R.A., Bielefeldt-Ohmann, H., The Australian public is still vulnerable to emerging virulent strains of WNV. Front. Public. Health, 2, 2014, 146.
15. [15] Graham, J.B., Thomas, S., Swarts, J., McMillan, A.A., Ferris, M.T., Suthar, M.S., Treuting, P.M., Ireton, R., Gale, M. Jr., Lund, J.M., Genetic diversity in the Collaborative Cross model recapitulates human WNV disease outcomes. mBio 6 (2015), e00493–e00515.
16. [16] Prow, N.A., Setoh, Y.X., Biron, R.M., Sester, D.P., Kim, K.S., Hobson-Peters, J., Hall, R.A., Bielefeldt-Ohmann, H., The WNV-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response. J. Virol. 88 (2014), 9947–9962.
17. [17] Suen, W.W., Prow, N.A., Hall, R.A., Bielefeldt-Ohmann, H., Mechanism of West Nile virus neuroinvasion: a critical appraisal. Viruses 6 (2014), 2796–2825.
18. [18] Mandl, J.N., Ahmed, R., Barreiro, L.B., Daszak, P., Epstein, J.H., Virgin, H.W., Feinberg, M.B., Reservoir host immune responses to emerging zoonotic viruses. Cell 160 (2015), 20–35.
19. [19] McClain, M.T., Henao, R., Williams, J., Nicholson, B., Veldman, T., Hudson, L., Tsalik, E.L., Lambkin-Williams, R., Gilbert, A., Mann, A., Ginsburg, G.S., Woods, C.W., Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. Clin. Exp. Immunol. 183 (2016), 441–451.
20. [20] Werner, J.M., Heller, T., Gordon, A.M., Sheets, A., Sherker, A.H., Kessler, E., Bean, K.S., Stevens, M., Schmitt, J., Rehermann, B., Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection. Hepatology 58 (2013), 1621–1631.
21. [21] Seok, J., Warren, H.S., Cuenca, A.G., Mindrinos, M.N., Baker, H.V., Xu, W., Richards, D.R., McDonald-Smith, G.P., Gao, H., Hennessy, L., Finnerty, C.C., López, C.M., Honari, S., Moore, E.E., Minei, J.P., Cuschieri, J., Bankey, P.E., Johnson, J.L., Sperry, J., Nathens, A.B., Billiar, T.R., West, M.A., Jeschke, M.G., Klein, M.B., Gamelli, R.L., Gibran, N.S., Brownstein, B.H., Miller-Graziano, C., Calvano, S.E., Mason, P.H., Cobb, J.P., Rahme, L.G., Lowry, S.F., Maier, R.V., Moldawer, L.L., Herndon, D.N., Davis, R.W., Xiao, W., Tompkins, R.G., Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 3507–3512.
22. [22] Suen, W.W., Uddin, M.J., Wang, W., Brown, V., Adney, D.R., Broad, N., Prow, N.A., Bowen, R.A., Hall, R.A., Bielefeldt-Ohmann, H., Experimental West Nile virus infection in rabbits: an alternative model for studying induction of disease and virus control. Pathogens 4 (2015), 529–558.
23. [23] Suen, W.W., Uddin, M.J., Prow, N.A., Bowen, R.A., Hall, R.A., Bielefeldt-Ohmann, H., Tissue-specific transcription profile of cytokine and chemokine genes associated with flavivirus control and non-lethal neuropathogenesis in rabbits. Virology 494 (2016), 1–14.
24. [24] Bielefeldt-Ohmann, H., Smirnova, N.P., Tolnay, A.E., Webb, B.T., Antoniazzi, A.Q., van Campen, H., Hansen, T.R., Neuro-invasion by a ‘Trojan Horse’ strategy and vasculopathy during intrauterine flavivirus infection. Int. J. Exp. Pathol. 93 (2012), 24–33.
25. [25] Miura, T.A., Travanty, E.A., Bielefeldt-Ohmann, H., Weiss, S.R., Beauchemin, N., Holmes, K.V., The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- mice. J. Virol. 82 (2008), 755–763.
26. [26] Tolnay, A.E., Baskin, C.R., Tumpey, T.M., Sabourin, P.J., Sabourin, C.L., Long, J.P., Pyles, J.A., Albrecht, R.A., Garcia-Sastre, A., Katze, M.G., Bielefeldt-Ohmann, H., Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch. Virol. 155 (2010), 905–914.
27. [27] Bowen, R.A., Nemeth, N.M., Experimental infections with West Nile virus. Curr. Opin. Infect. Dis. 20 (2007), 293–297.
28. [28] Uddin, M.J., Suen, W.W., Prow, N.A., Hall, R.A., Bielefeldt-Ohmann, H., West Nile virus challenge alters the transcription profiles of innate immune genes in rabbit peripheral mononuclear cells. Front. Vet. Sci., 2, 2015, 76.
29. [29] Uddin, M.J., Suen, W.W., Bosco-Laut, A., Hartwig, A.E., Hall, R.A., Bowen, R.A., Bielefeldt-Ohmann, H., Kinetic of the West Nile virus induced transcriptome for cytokines and Toll-like receptors in equine peripheral blood leukocytes. Vet. Res., 47, 2016, 61.
30. [30] Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res., 29, 2001, e45.
31. [31] Smirnova, N.P., Webb, B.T., Bielefeldt-Ohmann, H., Van Campen, H., Antoniazzi, A.Q., Morarie, S.E., Hansen, T.R., Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus. Virus Res. 167 (2012), 329–336.
32. [32] Schnupf, P., Sansonetti, P.J., Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection. PLoS ONE, 7, 2012, e36446.
33. [33] Bardina, S.V., Michlmayr, D., Hoffman, K.W., Obara, C.J., Sum, J., Charo, I.F., Lu, W., Pletnev, A.G., Lim, J.K., Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during West Nile virus infection. J. Immunol. 195 (2015), 4306–4318.
34. [34] Lim, J.K., Obara, C.J., Rivollier, A., Pletnev, A.G., Kelsall, B.L., Murphy, P.M., Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J. Immunol. 186 (2011), 471–478.
35. [35] Tiawsirisup, S., Platt, K.B., Tucker, B.J., Rowley, W.A., Eastern cottontail rabbits (Sylvilagus floridanus) develop west nile virus viremias sufficient for infecting select mosquito species. Vector Borne Zoonotic Dis. 5 (2005), 342–350.
36. [36] Baskin, C.R., Bielefeldt-Ohmann, H., García-Sastre, A., Tumpey, T.M., Van Hoeven, N., Carter, V.S., Thomas, M.J., Proll, S., Solórzano, A., Billharz, R., Fornek, J.L., Thomas, S., Chen, C.H., Clark, E.A., Murali-Krishna, K., Katze, M.G., Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J. Virol. 81 (2007), 11817–11827.
37. [37] Neves, P.C.C., Santos, J.R., Tubarão, L.N., Bonaldo, M.C., Galler, R., Early IFN-gamma production after yf17d vaccine virus immunization in mice and its association with adaptive immune responses. PLoS ONE, 8, 2013, e81953.
38. [38] Seino, K.K., Long, M.T., Gibbs, E.P., Bowen, R.A., Beachboard, S.E., Humphrey, P.P., Dixon, M.A., Bourgeois, M.A., Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin. Vaccine Immunol. 14 (2007), 1465–1471.
39. [39] Bielefeldt-Ohmann, H., Prow, N.A., Wang, W., Tan, C.S., Coyle, M., Douma, A., Hobson-Peters, J., Kidd, L., Hall, R.A., Petrovsky, N., Safety and immunogenicity of a delta inulin-adjuvanted Japanese encephalitis virus vaccine in pregnant mares and foals. Vet. Res., 45, 2014, 130.
40. [40] Barton, A.J., Prow, N.A., Hall, R.A., Kidd, L., Bielefeldt-Ohmann, H., A case of Murray Valley encephalitis in a 2-year-old Australia stock horse in south-east Queensland. Aust. Vet. J. 93 (2015), 53–57.
41. [41] Bowen, R.A., Rouge, M.M., Siger, L., Minke, J.M., Nordgren, R., Karaca, K., Johnson, J., Pathogenesis of West Nile virus infection in dogs treated with glucocorticoids. Am. J. Trop.Med. Hyg. 74 (2006), 670–673.
42. [42] Eidenschenk, C., Rutz, S., Liesenfeld, O., Ouyang, W., Role of IL-22 in microbial host defense. Curr. Top. Microbiol. Immunol. 380 (2014), 213–236.
43. [43] Karagianni, A.E., Kapetanovic, R., McGorum, B.C., Hume, D.A., Pirie, S.R., The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages. Vet. Immunol. Immunopathol. 155 (2013), 219–228.
44. [44] Almolda, B., de Labra, C., Barrera, I., Gruart, A., Delgado-Garcia, J.M., Villacampa, N., Vilella, A., Hofer, M.J., Hidalgo, J., Campbell, I.L., González, B., Castellano, B., Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocytes-targeted production of interleukin-10. Brain Behav. Immun. 45 (2015), 80–97.
45. [45] Villacampa, N., Almolda, B., Vilella, A., Campbell, I.L., Gonzalez, B., Castellano, B., Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy. Glia 63 (2015), 1166–1184.
46. [46] Swarup, V., Ghosh, J., Duseja, R., Ghosh, S., Basu, A., Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death. Neurosci. Lett. 420 (2007), 144–149.